Literature DB >> 25135469

Epidemiology of pulmonary hypertension and right ventricular failure in left heart failure.

Thenappan Thenappan1, Mardi Gomberg-Maitland.   

Abstract

Pulmonary hypertension (PH) leading to right ventricular failure (RVF) is a common complication of left heart failure irrespective of the left ventricular ejection fraction. PH due to left heart disease is the most common cause of PH. The prevalence of PH and RVF in left heart failure varies depending on the patient population studied, the method used to diagnose PH, and the hemodynamic criteria used to define PH. Elevated left-sided filling pressure and functional mitral regurgitation are the two major determinants of PH in left heart failure. PH is associated with markers of disease severity, advanced symptoms, and worse long-term outcomes including heart failure hospitalization and mortality in left heart failure. RVF has independent, incremental prognostic value over PH for adverse outcomes in left heart failure. PH and RVF may be potential therapeutic targets in patients with left heart failure.

Entities:  

Mesh:

Year:  2014        PMID: 25135469     DOI: 10.1007/s11897-014-0216-6

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  62 in total

1.  Comparative effects of aging in men and women on the properties of the arterial tree.

Authors:  H Smulyan; R G Asmar; A Rudnicki; G M London; M E Safar
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

2.  Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction.

Authors:  Sylvestre Maréchaux; Dan Valentin Neicu; Sophie Braun; Marjorie Richardson; Pascal Delsart; Nadia Bouabdallaoui; Carlo Banfi; Corinne Gautier; Pierre Graux; Philippe Asseman; Philippe Pibarot; Thierry H Le Jemtel; Pierre Vladimir Ennezat
Journal:  J Card Fail       Date:  2011-07-23       Impact factor: 5.712

3.  Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failure.

Authors:  Thomas P Olson; Eric M Snyder; Robert P Frantz; Stephen T Turner; Bruce D Johnson
Journal:  Am Heart J       Date:  2007-03       Impact factor: 4.749

4.  Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management.

Authors:  D L Moraes; W S Colucci; M M Givertz
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

5.  Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study.

Authors:  Benjamin R Szwejkowski; Douglas H J Elder; Fiona Shearer; David Jack; Anna Maria J Choy; Stuart D Pringle; Allan D Struthers; Jacob George; Chim C Lang
Journal:  Eur J Heart Fail       Date:  2011-12-16       Impact factor: 15.534

6.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

7.  The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Francisco Alpendurada; Kaushik Guha; Nizar A Ismail; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Kishen Morarji; Emmanouil Liodakis; Michael Roughton; Ricardo Wage; Tapesh C Pakrashi; Rakesh Sharma; John-Paul Carpenter; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  Circulation       Date:  2013-08-21       Impact factor: 29.690

8.  Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure.

Authors:  Wayne L Miller; Diane E Grill; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2013-08-05       Impact factor: 12.035

9.  Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Authors:  Amil M Shah; Sanjiv J Shah; Inder S Anand; Nancy K Sweitzer; Eileen O'Meara; John F Heitner; George Sopko; Guichu Li; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2013-11-18       Impact factor: 8.790

10.  Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.

Authors:  Andreas P Kalogeropoulos; Sarawut Siwamogsatham; Salim Hayek; Song Li; Anjan Deka; Catherine N Marti; Vasiliki V Georgiopoulou; Javed Butler
Journal:  J Am Heart Assoc       Date:  2014-02-03       Impact factor: 5.501

View more
  9 in total

Review 1.  Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.

Authors:  Christopher W Jensen; Andrew B Goldstone; Y Joseph Woo
Journal:  Curr Heart Fail Rep       Date:  2016-06

Review 2.  Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.

Authors:  Marco Guazzi; Valentina Labate
Journal:  Curr Heart Fail Rep       Date:  2016-12

Review 3.  Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF.

Authors:  Maria Barilli; Maria Cristina Tavera; Serafina Valente; Alberto Palazzuoli
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 4.  Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis.

Authors:  Jean Joel Bigna; Jean Jacques Noubiap; Jobert Richie Nansseu; Leopold Ndemnge Aminde
Journal:  BMC Pulm Med       Date:  2017-12-08       Impact factor: 3.317

5.  Prognostic value of cartilage intermediate layer protein 1 in chronic heart failure.

Authors:  Can Wang; Wen Jian; Qiuhu Luo; Jiasheng Cui; Yali Qing; Chunyu Qin; Gaoye Li; Wuxian Chen
Journal:  ESC Heart Fail       Date:  2021-12-22

6.  Spontaneous Degenerative Aortic Valve Disease in New Zealand Obese Mice.

Authors:  Christiane Ott; Kathleen Pappritz; Niklas Hegemann; Cathleen John; Sarah Jeuthe; Cameron S McAlpine; Yoshiko Iwamoto; Jonathan H Lauryn; Jan Klages; Robert Klopfleisch; Sophie Van Linthout; Fil Swirski; Matthias Nahrendorf; Ulrich Kintscher; Tilman Grune; Wolfgang M Kuebler; Jana Grune
Journal:  J Am Heart Assoc       Date:  2021-11-15       Impact factor: 6.106

Review 7.  Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors.

Authors:  Artem Ovchinnikov; Alexandra Potekhina; Evgeny Belyavskiy; Fail Ageev
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-19

8.  Prevalence and determinants of pulmonary hypertension in a group of Cameroonian patients without chronic lung disease: a cross-sectional echocardiographic study.

Authors:  Ahmadou M Jingi; Jean Jacques Noubiap; Aurel T Tankeu; Liliane Mfeukeu-Kuate; Clovis Nkoke; Philippe Kamdem; Alain Patrick Menanga; Samuel Kingue
Journal:  BMC Res Notes       Date:  2017-11-07

9.  Biomechanical and Hemodynamic Measures of Right Ventricular Diastolic Function: Translating Tissue Biomechanics to Clinical Relevance.

Authors:  Sae Jang; Rebecca R Vanderpool; Reza Avazmohammadi; Eugene Lapshin; Timothy N Bachman; Michael Sacks; Marc A Simon
Journal:  J Am Heart Assoc       Date:  2017-09-12       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.